Table 2.
B6 | B6/129.Igh b | Cr2 −/− | C4 +/− | C4 −/− | ||||||
---|---|---|---|---|---|---|---|---|---|---|
female | male | female | male | female | male | female | male | female | male | |
n | 30 | 20 | 33 | 23 | 23 | 45 | 21 | 20 | 38 | 21 |
ANA percent positive | 30 | 15 | 27 | 35 | 43 | 31 | 38 | 25 | 100 | 67 |
Range (titer) | 0–360 | 0–120 | 0–360 | 0–360 | 0–1,080 | 0–360 | 0–1,080 | 0–360 | 120–29,160 | 0–9,720 |
Median | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,080 | 120 |
χ2 (P) | ns | ns | – | – | ns | ns | ns | ns | <0.00001 | <0.05 |
Anti-ssDNA percent positive | 13 | 0 | 18 | 13 | 22 | 9 | 10 | 0 | 84 | 29 |
Range (μg/ml) | 0–11 | 0 | 0–150 | 0–32 | 0–38 | 0–10 | 0–4 | 0 | 0–286 | 0–357 |
Median | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 0 |
χ2 (P) | ns | ns | – | – | ns | ns | ns | ns | <0.00001 | ns |
Anti-dsDNA percent positive | 7 | 0 | 15 | 4 | 26 | 7 | 14 | 5 | 76 | 14 |
Range (μg/ml) | 0–12 | 0 | 0–150 | 0–30 | 0–55 | 0–12 | 0–5 | 0–3 | 0–318 | 0–260 |
Median | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 |
χ2 (P) | ns | ns | – | – | ns | ns | ns | ns | <0.00001 | ns |
Anti-nDNA percent positive | 10 | 0 | 9 | 4 | 9 | 7 | 0 | 0 | 58 | 14 |
Range (titer) | 0–20 | 0 | 0–20 | 0–10 | 0–20 | 0–20 | 0 | 0 | 0–160 | 0–80 |
Median | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 |
χ2 (P) | ns | ns | – | – | ns | ns | ns | ns | <0.00005 | ns |